STOCK TITAN

Xencor: BVF Partners deemed owner of about 8.4%

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Xencor Inc. (XNCR) is the issuer in an amended beneficial-ownership report by Biotechnology Value Fund, L.P. (BVF), Biotechnology Value Fund II, L.P. (BVF2) and Biotechnology Value Trading Fund OS LP. As of September 30, 2026, they reported 3,263,494 shares (approximately 4.4%), 2,446,552 shares (approximately 3.3%) and 410,748 shares (less than 1%), respectively.

BVF I GP LLC and BVF II GP LLC may be deemed to own their respective funds’ shares; BVF Partners OS Ltd. may be deemed to own Trading Fund OS’s shares. BVF GP Holdings LLC, sole member of the first two general partners, may be deemed to own 5,710,046 shares (7.7%). BVF Partners L.P., investment manager of the three funds and sole member of BVF Partners OS Ltd.; BVF Inc., its general partner; and Mark N. Lampert, a director and officer of BVF Inc., may each be deemed to own 6,227,034 shares (approximately 8.4%) through shared voting and dispositive power. That figure includes 106,240 shares in the Partners Managed Account. The reporting persons state that deemed ownership is not itself an admission of ownership of another reporting person’s shares and disclose beneficial-ownership disclaimers.

BVF beneficial ownership 3,263,494 shares; approximately 4.4% Reported as of September 30, 2026
BVF2 beneficial ownership 2,446,552 shares; approximately 3.3% Reported as of September 30, 2026
Trading Fund OS beneficial ownership 410,748 shares; less than 1% Reported as of September 30, 2026
BVF GP Holdings LLC deemed beneficial ownership 5,710,046 shares; approximately 7.7% Shares beneficially owned in aggregate by BVF and BVF2; reported as of September 30, 2026
Partners, BVF Inc. and Mark N. Lampert deemed beneficial ownership 6,227,034 shares; approximately 8.4% Reported as of September 30, 2026; includes 106,240 shares held in the Partners Managed Account
Xencor shares outstanding 74,353,397 shares As of July 31, 2026; basis for the reported ownership percentages
Partners Managed Account shares 106,240 shares Included in the 6,227,034 shares attributed to Partners, BVF Inc. and Mark N. Lampert
beneficial ownership regulatory
"beneficially owned 3,263,494 shares"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared voting power regulatory
"through shared voting and dispositive power"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"through shared voting and dispositive power"
Partners Managed Account financial
"106,240 shares in the Partners Managed Account"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many XNCR shares did each BVF fund report?

As of September 30, 2026, BVF reported 3,263,494 shares, BVF2 reported 2,446,552 shares, and Trading Fund OS reported 410,748 shares. Their reported percentages were approximately 4.4%, approximately 3.3%, and less than 1%, respectively.

Why do BVF affiliates and Mark N. Lampert report 6,227,034 XNCR shares?

BVF Partners L.P., BVF Inc. and Mark N. Lampert may each be deemed to beneficially own 6,227,034 shares through shared voting and dispositive power. Lampert is a director and officer of BVF Inc.; the reporting persons also state that deemed ownership does not itself admit ownership of another reporting person’s shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





98401F105

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



BIOTECHNOLOGY VALUE FUND L P
Signature:/s/ Mark N. Lampert
Name/Title:Mark N. Lampert, Authorized Signatory
Date:11/16/2026
BVF I GP LLC
Signature:/s/ Mark N. Lampert
Name/Title:Mark N. Lampert, Authorized Signatory
Date:11/16/2026
BIOTECHNOLOGY VALUE FUND II LP
Signature:/s/ Mark N. Lampert
Name/Title:Mark N. Lampert, Authorized Signatory
Date:11/16/2026
BVF II GP LLC
Signature:/s/ Mark N. Lampert
Name/Title:Mark N. Lampert, Authorized Signatory
Date:11/16/2026
Biotechnology Value Trading Fund OS LP
Signature:/s/ Mark N. Lampert
Name/Title:Mark N. Lampert, Authorized Signatory
Date:11/16/2026
BVF Partners OS Ltd.
Signature:/s/ Mark N. Lampert
Name/Title:Mark N. Lampert, Authorized Signatory
Date:11/16/2026
BVF GP HOLDINGS LLC
Signature:/s/ Mark N. Lampert
Name/Title:Mark N. Lampert, Authorized Signatory
Date:11/16/2026
BVF PARTNERS L P/IL
Signature:/s/ Mark N. Lampert
Name/Title:Mark N. Lampert, Authorized Signatory
Date:11/16/2026
BVF INC/IL
Signature:/s/ Mark N. Lampert
Name/Title:Mark N. Lampert, Authorized Signatory
Date:11/16/2026
LAMPERT MARK N
Signature:/s/ Mark N. Lampert
Name/Title:Mark N. Lampert
Date:11/16/2026

Keep reading